Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiwei Wu

Showing results (191-200 of 257) with videos related to

Pageof 26
Sort By:
Cancer Immunology Research|June 14, 2018
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint ProfileChristiane Querfeld, Samantha Leung, Patricia L Myskowski, et al.
Cancer Research|April 5, 2012
CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cellsAkihiro Tsuyada, Amy Chow, Jun Wu, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Iscience|September 18, 2020
A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
The Journal of Clinical Investigation|August 1, 2023
Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activityQinjian Li, Xiaoqi Wang, Qingxiao Song, et al.
Cell Reports|April 12, 2018
JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor CellsSihui Li, Shafat Ali, Xiaotao Duan, et al.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Nature Cell Biology|April 18, 2018
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cellsWei Yan, Xiwei Wu, Weiying Zhou, et al.
Leukemia & Lymphoma|April 10, 2020
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 studyMichael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, et al.
Stem Cell Reports|August 23, 2016
L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem CellsZhongqi Li, Diana Oganesyan, Rachael Mooney, et al.
Pageof 26

Showing results (191-200 of 257) with videos related to

Sort By:
Pageof 26
Cancer Immunology Research|June 14, 2018
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint ProfileChristiane Querfeld, Samantha Leung, Patricia L Myskowski, et al.
Cancer Research|April 5, 2012
CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cellsAkihiro Tsuyada, Amy Chow, Jun Wu, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Iscience|September 18, 2020
A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
The Journal of Clinical Investigation|August 1, 2023
Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activityQinjian Li, Xiaoqi Wang, Qingxiao Song, et al.
Cell Reports|April 12, 2018
JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor CellsSihui Li, Shafat Ali, Xiaotao Duan, et al.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Nature Cell Biology|April 18, 2018
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cellsWei Yan, Xiwei Wu, Weiying Zhou, et al.
Leukemia & Lymphoma|April 10, 2020
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 studyMichael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, et al.
Stem Cell Reports|August 23, 2016
L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem CellsZhongqi Li, Diana Oganesyan, Rachael Mooney, et al.
Pageof 26